Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Fischer

Showing results (231-240 of 489) with videos related to

Pageof 49
Sort By:
Clinical Hemorheology and Microcirculation|December 18, 2020
Contrast enhanced ultrasound (CEUS) with parametric imaging after irreversible electroporation (IRE) of the prostate to assess the success of prostate cancer treatmentErnst Michael Jung, Martin Engel, Philipp Wiggermann, et al.
Nanoscale|November 18, 2010
Miniaturized ionization gas sensors from single metal oxide nanowiresFrancisco Hernandez-Ramirez, Juan Daniel Prades, Angelika Hackner, et al.
Nuklearmedizin. Nuclear Medicine|December 17, 2021
Treatment outcome and identification of factors influencing overall survival after Lu-177-PSMA-617 radioligand therapy in metastatic prostate cancerCharlotte A Schneider, Philipp Täger, Jochen Hammes, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 19, 2005
Magnetic resonance imaging of the upper abdomen using a free-breathing T2-weighted turbo spin echo sequence with navigator triggered prospective acquisition correctionChristian Klessen, Patrick Asbach, Thomas J Kroencke, et al.
Nuclear Medicine Communications|March 15, 2006
Cell death induced by 131 I in a differentiated thyroid carcinoma cell line in vitro: necrosis or apoptosis?Kathrin Marx, Detlef Moka, Klaus Schomäcker, et al.
Blood Advances|September 30, 2021
Anti-inflammatory treatment in MPN: targeting TNFR1 and TNFR2 in JAK2-V617F-induced diseasePeter Müller, Conny K Baldauf, Tobias R Haage, et al.
Blood Advances|September 24, 2021
Anti-IL-6 cytokine treatment has no impact on elevated hematocrit or splenomegaly in a polycythemia vera mouse modelConny K Baldauf, Peter Müller, Tobias R Haage, et al.
Molecules (Basel, Switzerland)|January 11, 2024
From Bench to Bedside: Patient-Oriented Radiopharmaceutical Development in Nuclear Medicine Based on the Example of [<sup>89</sup>Zr]Zr-PSMA-DFOKlaus Schomäcker, Felix Dietlein, Sergio Muñoz Vázquez, et al.
BMC Cancer|November 12, 2021
Opposite effects of the triple target (DNA-PK/PI3K/mTOR) inhibitor PI-103 on the radiation sensitivity of glioblastoma cell lines proficient and deficient in DNA-PKcsCholpon S Djuzenova, Thomas Fischer, Astrid Katzer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 23, 2011
In vitro metabolism of rivoglitazone, a novel peroxisome proliferator-activated receptor γ agonist, in rat, monkey, and human liver microsomes and freshly isolated hepatocytesMinoru Uchiyama, Hiroko Koda, Thomas Fischer, et al.
Pageof 49

Showing results (231-240 of 489) with videos related to

Sort By:
Pageof 49
Clinical Hemorheology and Microcirculation|December 18, 2020
Contrast enhanced ultrasound (CEUS) with parametric imaging after irreversible electroporation (IRE) of the prostate to assess the success of prostate cancer treatmentErnst Michael Jung, Martin Engel, Philipp Wiggermann, et al.
Nanoscale|November 18, 2010
Miniaturized ionization gas sensors from single metal oxide nanowiresFrancisco Hernandez-Ramirez, Juan Daniel Prades, Angelika Hackner, et al.
Nuklearmedizin. Nuclear Medicine|December 17, 2021
Treatment outcome and identification of factors influencing overall survival after Lu-177-PSMA-617 radioligand therapy in metastatic prostate cancerCharlotte A Schneider, Philipp Täger, Jochen Hammes, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 19, 2005
Magnetic resonance imaging of the upper abdomen using a free-breathing T2-weighted turbo spin echo sequence with navigator triggered prospective acquisition correctionChristian Klessen, Patrick Asbach, Thomas J Kroencke, et al.
Nuclear Medicine Communications|March 15, 2006
Cell death induced by 131 I in a differentiated thyroid carcinoma cell line in vitro: necrosis or apoptosis?Kathrin Marx, Detlef Moka, Klaus Schomäcker, et al.
Blood Advances|September 30, 2021
Anti-inflammatory treatment in MPN: targeting TNFR1 and TNFR2 in JAK2-V617F-induced diseasePeter Müller, Conny K Baldauf, Tobias R Haage, et al.
Blood Advances|September 24, 2021
Anti-IL-6 cytokine treatment has no impact on elevated hematocrit or splenomegaly in a polycythemia vera mouse modelConny K Baldauf, Peter Müller, Tobias R Haage, et al.
Molecules (Basel, Switzerland)|January 11, 2024
From Bench to Bedside: Patient-Oriented Radiopharmaceutical Development in Nuclear Medicine Based on the Example of [<sup>89</sup>Zr]Zr-PSMA-DFOKlaus Schomäcker, Felix Dietlein, Sergio Muñoz Vázquez, et al.
BMC Cancer|November 12, 2021
Opposite effects of the triple target (DNA-PK/PI3K/mTOR) inhibitor PI-103 on the radiation sensitivity of glioblastoma cell lines proficient and deficient in DNA-PKcsCholpon S Djuzenova, Thomas Fischer, Astrid Katzer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 23, 2011
In vitro metabolism of rivoglitazone, a novel peroxisome proliferator-activated receptor γ agonist, in rat, monkey, and human liver microsomes and freshly isolated hepatocytesMinoru Uchiyama, Hiroko Koda, Thomas Fischer, et al.
Pageof 49